HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
PR 546
no other info available 9/89
Also Known As:
PR-546
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones: 80400
Peptide Hormones: 1347
Hypothalamic Hormones: 68
Pituitary Hormone-Releasing Hormones: 39
Thyrotropin-Releasing Hormone: 1449
PR 546: 2
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Nerve Tissue Proteins: 2
Neuropeptides: 6772
Thyrotropin-Releasing Hormone: 1449
PR 546: 2
Hypothalamic Hormones: 68
Pituitary Hormone-Releasing Hormones: 39
Thyrotropin-Releasing Hormone: 1449
PR 546: 2
Peptides: 82426
Neuropeptides: 6772
Hypothalamic Hormones: 68
Pituitary Hormone-Releasing Hormones: 39
Thyrotropin-Releasing Hormone: 1449
PR 546: 2
Peptide Hormones: 1347
Hypothalamic Hormones: 68
Pituitary Hormone-Releasing Hormones: 39
Thyrotropin-Releasing Hormone: 1449
PR 546: 2
Oligopeptides: 519
Thyrotropin-Releasing Hormone: 1449
PR 546: 2
Related Diseases
1.
Hyperventilation
07/01/1989 - "
PR-546 (in doses 100-500 micrograms/kg) intravenously injected was shown to abolish diagram activity decreased effect after hyperventilation.
"
2.
Edema (Dropsy)
05/01/1990 - "
It was proved that the preliminary (for 30 min before the injury) i/p introduction of TRH (in doses 0.5-1 mg/kg) and PR-546 (in doses 4-8 mg/kg) prevented the development of acute edema and the changes of blood gas compositions as well as disorders in breathing after skull injury.
"